Pulse Intravenous Cyclophosphamide Therapy in Pemphigus
Authors:
- Rachel H. ValekRVRachel H. Valek
- Amit G. PandyaAPAmit G. Pandya
Open Access
- 1 January 1999
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 135 (1) , 57-61
Abstract
Background Adjuvant therapy is commonly used in pemphigus to mitigate the high morbidity and mortality associated with the use of corticosteroids and improve disease control. However, these adjuvant agents are not without adverse effects of their own, including an increased risk of malignancy with the use of oral immunosuppressives. Intravenous pulse cyclophosphamide, which may be more efficacious and less toxic than oral immunosuppressives, has been used successfully in the treatment of pemphigus. Objective To review 9 patients with severe or previously recalcitrant pemphigus who were treated with intravenous pulse cyclophosphamide therapy. Results Six of the 9 patients responded to therapy, with 2 patients achieving remission from skin lesions. Five patients were able to decrease their daily dose of prednisone, and 1 was able to discontinue the use of prednisone completely. Most patients experienced minimal or no adverse effects. Conclusions Intravenous pulse cyclophosphamide may be an alternative treatment option in patients with pemphigus recalcitrant to standard therapy. The decreased cumulative dose of cyclophosphamide observed with monthly pulse doses may reduce the incidence of secondary malignancies when compared with continuous oral therapy. Controlled trials are needed to further evaluate the efficacy of this mode of therapy.Keywords
This publication has 22 references indexed in Scilit:
- The efficacy of combined treatment with prednisone and cyclosporine in patients with pemphigus: Preliminary studyJournal of the American Academy of Dermatology, 1994
- The Course and Prognosis of PemphigusInternational Journal of Dermatology, 1988
- Intermittent high-dose dexamethasone-cyclophosphamide therapy for pemphigusBritish Journal of Dermatology, 1988
- Treatment of nine cases of pemphigus vulgaris with cyclosporineJournal of the American Academy of Dermatology, 1988
- Use of cyclophosphamide in azathioprine failures in pemphigusJournal of the American Academy of Dermatology, 1987
- Malignancy following treatment of rheumatoid arthritis with cyclophosphamideThe American Journal of Medicine, 1987
- Dapsone as initial treatment in superficial pemphigus. Report of nine casesArchives of Dermatology, 1987
- Pemphigus vulgaris: Results of treatment with gold as a steroid-sparing agent in a series of thirteen patientsJournal of the American Academy of Dermatology, 1984
- Pemphigus: a 20-year review of 107 patients treated with corticosteroidsArchives of Dermatology, 1976
- Pemphigus. A 20-year survey of experience with 70 casesArchives of Dermatology, 1971